Main

Main

CRISPR Therapeutics AG. 38.74. -0.37. -0.95%. Get Ginkgo Bioworks (DNA:NYSE) real-time stock quotes, news, price and financial information from CNBC.BOSTON, Aug. 4, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced that Kathy Hopinkah Hannan, PhD, CPA has joined its Board of ...The average twelve-month price prediction for Ginkgo Bioworks is $3.44 with a high price target of $6.00 and a low price target of $1.25. Learn more on DNA's analyst rating history. Do Wall Street analysts like Ginkgo Bioworks more than its competitors?1,292. Jason Kelly. https://www.ginkgobioworks.com. Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum.Ginkgo reiterated its expectations of 55-60 new Cell Programs added to the Foundry platform in 2022. Ginkgo continues to expect Total revenue of $460 – 480 million in 2022. Preliminary unaudited ...Aug 5, 2022 · Synthetic biology company Ginkgo Bioworks Holdings (DNA-3.50%) is down roughly 80% from its highs posted late last year. But rapidly growing revenues and a hefty cash balance, combined with ... Get the latest Ginkgo Bioworks (DNA+) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Ginkgo Bioworks Holdings Inc (NYSE:DNA) is a leading player in the synthetic biology space with a strong focus on engineering microbes for various industrial applications. The company has a strong ...SAN DIEGO, March 29, 2023 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating Provention Bio, Inc., Maxar Technologies Inc., Ginkgo Bioworks Holdings, Inc., and Fox Corporation ...NYSE: DNA Ginkgo Bioworks. Market Cap. $3B. Today's Change (-3.50%) -$0.06. Current Price. $1.51. ... (DNA-3.50%) is down roughly 80% from its highs posted late last year. But rapidly growing ...DNA - Ginkgo Bioworks Holdings Inc - Class A Stock - Stock Price, Institutional Ownership, Shareholders (NYSE)ARWR. Arrowhead Pharmaceuticals Inc. 25.99. -1.03. -3.81%. Get Ginkgo Bioworks (DNA:NYSE) real-time stock quotes, news, price and financial information from CNBC. You can practice and explore trading DNA stock methods without spending real money on the virtual. Webull offers DNA Ent Holdg (DNA) historical stock prices, in-depth market analysis, NYSE: DNA real-time stock quote data, in-depth charts, free DNA options chain data, and a fully built financial calendar to help you invest smart. Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) is a Massachusetts-based company that develops a platform for cell programming, which is used to program cells to allow biological production of novel ...Is Ginkgo Bioworks Holdings (NYSE:DNA) a buy? Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, ...Dec 24, 2022 · Gingko Bioworks’ (NYSE: DNA) business model is to produce drugs using synthetic biology, designed with genetic engineering. It offers to produce these drugs at cost, in what it calls a foundry ... Lastly, Wood’s ETFs have a combined 164.76 million shares of Ginkgo Bioworks (NYSE: DNA).It is a pioneering biotechnology company revolutionizing the industry with its customer-centric approach ...NYSE: DNA · IEX Real-Time Price · USD. Add to Watchlist 1.35-0.11 (-7.53%) Oct 27, 2023, 4:00 PM EDT - Market closed. Overview; ... Stock Price Forecast. …DNA Stock 12 Months Forecast. $4.58. (213.70% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Ginkgo Bioworks Holdings in the last 3 months. The average price target is $4.58 with a high forecast of $12.00 and a low forecast of $1.50. The average price target represents a 213.70% change from the last price of $1.46.NYSE: DNA · IEX Real-Time Price · USD. Add to Watchlist 1.35-0.11 (-7.53%) Oct 27, 2023, 4:00 PM EDT - Market closed. Overview; ... Stock Price Forecast. …Ginkgo Bioworks Holdings (NYSE: DNA) reported its Q1 2022 financial results on May 16 and the results were mixed, depending on your point of view. For me, the bottom line, a widening net loss ...SAN FRANCISCO, Oct. 7, 2021 /PRNewswire/ -- Hagens Berman urges Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) investors with significant losses to submit your losses now.Oct 29, 2023 · 1,292. Jason Kelly. https://www.ginkgobioworks.com. Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. MALVERN, Pa. — Oct. 26, 2023 — Vishay Intertechnology, Inc. (NYSE: VSH) today announced the release of a new series of wet tantalum capacitors with hermetic glass-to …Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Get Free Report) dropped 6.2% during trading on Friday following insider selling activity.The stock traded as low as $1.36 and last traded at $1.37 ...BOSTON, Aug. 7, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new collaboration with Merck & Co., known as MSD outside of the United States and Canada, focused on improving biologic manufacturing. Ginkgo will apply its expertise and capabilities ...DNA Earnings Date and Information. Ginkgo Bioworks last posted its quarterly earnings results on August 9th, 2023. The reported ($0.09) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.09). The firm had revenue of $80.57 million for the quarter, compared to analyst estimates of $70.41 million.BOSTON, Dec. 20, 2021 /PRNewswire/ -- Benjamin Franklin Institute of Technology (BFIT), a private non-profit college offering affordable education for people seeking technical and trade careers, announced today a partnership with Ginkgo Bioworks (NYSE: DNA) to develop an associate degree in biotechnology manufacturing. The program will be …iGlobe Partners is a premier global venture capital fund manager founded in 1999 in Silicon Valley and headquartered in Singapore today. With an extensive and global network, the firm has a strong ...Don’t let the currency conversion trip you up. Convert Ginkgo Bioworks Holdings stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. …Ginkgo Bioworks Holdings (NYSE: DNA) is owned by 56.84% institutional shareholders, 14.46% Ginkgo Bioworks Holdings insiders, and 28.70% retail investors. Cascade Investment LLC is the largest individual Ginkgo Bioworks Holdings shareholder, owning 151.87M shares representing 7.24% of the company.Research Mueller Industries' (NYSE:MLI) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. ... (NYSE:MLI) Might Have The DNA Of A Multi-Bagger Jun 08. Investor sentiment improves as stock rises 16% Jun 08. Chairman of the Board & CEO recently sold US$2.7m worth …Ginkgo Bioworks ( NYSE: DNA) stock jumped 9% in early trading after it announced it was teaming up with Pfizer ( PFE) to develop RNA-based drug candidates. Under the deal, Ginkgo will receive an ...- Today, Ginkgo Bioworks (NYSE: DNA) — the leading horizontal platform for cell programming — and the biotechnology company Zymergen (Nasdaq: ZY) announced they have entered into a definitive ...Complete Ginkgo Bioworks Holdings Inc. stock information by Barron's. View real-time DNA stock price and news, along with industry-best analysis. Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Snap, Novavax, Zillow, and Ginkgo Bioworks and Encourages Investors to Contact the FirmMar 21, 2023 · So when California-based Zymergen became a part of Ginkgo (NYSE: DNA) last year, its technology became a near-seamless part of Ginkgo's toolkit. "Like Lego pieces you could take in and out," said ... Institutional owners may consider drastic measures as Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) recent US$188m drop adds to long-term losses Read full article Simply Wall StGenentech Inc (NYSE:DNA), a biotechnology company dedicated to developing life-saving medicines, has invested over $250 million in a new biological facility that will reduce its environmental ...DNA:NYQ. Select symbol. United States; DNA:NYQNYSE · DNA:ASENYSE American · DNA:NYSNYSE; Germany; 9L4:BERBerlin Stock Exchange; Mexico; DNA*:MEXMexico Stock ...Market Capitalization. $3.34 billion. P/E Ratio. N/A. Dividend Yield. N/A. Price Target. $3.44. Stock Analysis Analyst Forecasts Chart Competitors Earnings Financials Insider Trades Ownership Headlines Options Chain SEC Filings Short Interest Social Media.Ginkgo Bioworks HoldingsStock , DNA. 1.57+0.01+0.64%. 04:15:01 PM EDT 10/20/2023. NYSE. Start Trading. Add to watchlist. Plus500. 81% of retail CFD accounts ...Ginkgo Bioworks Holdings Inc (NYSE:DNA) 1.44 Delayed Data As of Oct 25 -0.135 / -8.60% Today’s Change 1.12 Today ||| 52-Week Range 3.01 -15.09% Year-to-Date Quote Profile News Charts Forecasts... TORONTO and BOSTON, June 21, 2022 /PRNewswire/ -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos"), an innovative global cannabinoid company, and Ginkgo Bioworks (NYSE: DNA) ("Ginkgo"), the ...Ginkgo Bioworks Holdings, Inc.'s stock symbol is DNA and currently trades under NYSE. It's current price per share is approximately $1.33. What are your Ginkgo ...BOSTON, Dec. 20, 2021 /PRNewswire/ -- Benjamin Franklin Institute of Technology (BFIT), a private non-profit college offering affordable education for people seeking technical and trade careers, announced today a partnership with Ginkgo Bioworks (NYSE: DNA) to develop an associate degree in biotechnology manufacturing. The program will be …DNA | Complete Ginkgo Bioworks Holdings Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.BOSTON, Sept. 30, 2021 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. , which is building the leading horizontal platform for cell programming, announced today that management is scheduled to... | March 26, 2023Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Get Free Report) dropped 6.2% during trading on Friday following insider selling activity.The stock traded as low as $1.36 and last traded at $1.37 ...2023年7月15日 ... The most damning piece of evidence came in March, when detectives tailing Heuermann recovered DNA ... RAW: NYSE: CLOSING BELL (FRIDAY).These insights can, in turn, lead to better-informed investment decisions. Throughout this series, I will be analyzing companies based on the five forces: Threat of Competition. Threat of New ...View the latest Ginkgo Bioworks Holdings Inc. (DNA) stock price, news, historical charts, analyst ratings and financial information from WSJ. SAN DIEGO, March 29, 2023 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating Provention Bio, Inc., Maxar Technologies Inc., Ginkgo Bioworks Holdings, Inc., and Fox Corporation ...- Today, Ginkgo Bioworks (NYSE: DNA) — the leading horizontal platform for cell programming — and the biotechnology company Zymergen (Nasdaq: ZY) announced they have entered into a definitive ...As a member of the SPAC class of 2021, Ginkgo Bioworks ( NYSE: DNA) stock has seen its fair share of pummeling over the last few years. From an all-time high at ~$16 to the stock's current price ...View real-time DNA stock price and news, along with industry-best analysis. ... Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE ...Gingko Bioworks’ (NYSE: DNA) business model is to produce drugs using synthetic biology, designed with genetic engineering. It offers to produce these drugs at cost, in what it calls a foundry ...Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, and the Government of Serbia today...TORONTO and BOSTON, June 21, 2022 /PRNewswire/ -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos"), an innovative global cannabinoid company, and Ginkgo Bioworks (NYSE: DNA) ("Ginkgo"), the ...SAN FRANCISCO, Oct. 7, 2021 /PRNewswire/ -- Hagens Berman urges Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) investors with significant losses to submit your losses now.Ginkgo Bioworks Holdings, Inc. (DNA) NYSE - Nasdaq Real Time Price. Currency in USD Follow 2W 10W 9M 1.4600 +0.0200 (+1.39%) At close: 04:00PM EDT Oct 30, 2023. GSK will extend its collaboration agreement with 23andMe and pay $20 million upfront for a one-year, non-exclusive data license that will give it further access to the genetics ...BOSTON, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) for potential securities law violations.Ginkgo Bioworks (NYSE: DNA) A Snake Oil Salesman And Some Hedge Funds Partner Up To Pimp The Latest “Synthetic Biology” Scam — As Phantom Revenue, A Hocus-Pocus Business Model, Rampant Related-Party Games, And A Decade of Colossal Failure Get Shoveled Into Yet Another Garbage SPAC.4 Wall Street research analysts have issued 1-year price targets for Ginkgo Bioworks' shares. Their DNA share price targets range from $1.25 to $6.00. On average, they anticipate the company's stock price to reach $3.44 in the next year. This suggests a possible upside of 139.5% from the stock's current price.For fans of the biotech boom, today marks an important debut as Ginkgo Bioworks (NYSE: DNA) begins trading. The company opted to go public by way of a SPAC, merging with Soaring Eagle Acquisition ...Find the latest Ginkgo Bioworks Holdings, Inc. (DNA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Snap, Novavax, Zillow, and Ginkgo Bioworks and Encourages Investors to Contact the FirmGinkgo Bioworks Holdings Inc (DNA) Stock Price & News - Google Finance Markets -2.43% 1,651.43 -1.67% -28.07 Home DNA • NYSE Ginkgo Bioworks Holdings Inc Follow Share $1.44 After Hours:...Ginkgo Bioworks Holdings, Inc. (NYSE:NYSE:DNA) Q3 2021 Earnings Conference Call November 15, 2021 8:00 AM ETCompany ParticipantsAnna Marie Wagner - Senior Vice President of Corporate...Ginkgo Bioworks (NYSE: DNA) $1.57 (5.4%) $0.08 Price as of October 24, 2023, 4:00 p.m. ET Overview Financial Health Valuation Related Stocks Key Data Points Current Price …1,292. Jason Kelly. https://www.ginkgobioworks.com. Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum.Mar 17, 2022 · In summary, Ginkgo Bioworks probably isn't the right stock for Warren Buffett. But it could potentially be right for those who are willing to consider a more speculative biotech investment. Either ... BOSTON, June 7, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA ), the leading horizontal platform for cell programming, today announced a collaboration with Novo Nordisk, a leading global ...- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that it plans to host a presentation and Q&A session reviewing business performance for the ...DNA Net Income (Quarterly) data by YCharts. Investors shouldn't expect a turnaround soon. Ginkgo is a risky stock to own. And at nearly 5 times its trailing revenue, it's still not a cheap buy. As ...Dec 8, 2022 · BOSTON, Dec. 8, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the launch of Ginkgo Enzyme Services ... Open 1.47 Day High 1.47 Day Low 1.35 Prev Close 1.46 52 Week High 2.94 52 Week High Date 11/11/22 52 Week Low 1.12 52 Week Low Date 05/03/23 Market Cap 2.671B Shares Out 1.98B 10 Day Average Volume...Ginkgo Bioworks' ( NYSE: DNA) first quarter results were something of a mixed bag, with continued progression on a number of metrics offset by rising costs and declining revenues. Ginkgo's success ...View the latest Ginkgo Bioworks Holdings Inc. (DNA) stock price, news, historical charts, analyst ratings and financial information from WSJ.Morningstar Rating | Rating as of Oct 25, 2023 Quote Chart Stock Analysis News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating Performance Dividends Ownership...DNA:NYQ. Select symbol. United States; DNA:NYQNYSE · DNA:ASENYSE American · DNA:NYSNYSE; Germany; 9L4:BERBerlin Stock Exchange; Mexico; DNA*:MEXMexico Stock ...Humans, however, have recently invented two very important technologies—reading and writing DNA. In 1952, Rosalind Franklin took the first X-ray picture of DNA. Her image showed that DNA was a double helix, a twisted ladder of paired “letters” that made a molecular code. The code was made up of A’s, T’s, C’s, and G’s instead of 0 ...History. In 2014, Ginkgo was the first biotechnology company to join the Y Combinator start-up accelerator program. [1] On 16 December 2020, it was reported that Ginkgo Bioworks …